SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-15-006738
Filing Date
2015-11-03
Accepted
2015-11-03 17:25:40
Documents
3
Period of Report
2015-10-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctix_8k.htm 8-K 14866
2 AMENDED AND RESTATED BYLAWS ctix_ex31.htm EX-3.1 88016
3 AMENDED AND RESTATED BYLAWS ctix_ex32.htm EX-3.2 124229
  Complete submission text file 0001477932-15-006738.txt   228362
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 151194691
SIC: 2834 Pharmaceutical Preparations